stirring at 85 ◦C for 6 h, the reaction was cooled and the solvents
were removed under reduced atmosphere. Purification of the
residue by column chromatography (hexane–AcOEt = 5 : 1, v/v)
yielded a colourless liquid (2.80 g, 9.40 mmol, 56% yield). Spectral
data coincided with the previous data.13
Scheme 7 Preparation of lithiated dithiane 26.
General procedure
chromatography on silica gel, using AcOEt–hexane as eluant,
yielded the ring-opening product.
Typical procedure A. A solution of 1,3-dithiane or 2-Ph-1,3-
dithiane (0.550 mmol, 1.10 equiv.) in THF (3.00 mL) was cooled
◦
n
to -78 C and treated with a ~1.6 M hexane solution of BuLi
(0.550 mmol, 1.10 equiv.) dropwise via syringe. After 2 h, a solution
of the selected aziridine (0.500 mmol) in THF (2.00 mL) was
added dropwise to the reaction mixture at -78 ◦C via syringe.
The resultant solution was warmed to 0 ◦C and stirred for 3 h,
and then poured into excess HCl in MeOH and concentrated in
vacuo. Flash chromatography on silica gel, using AcOEt–hexane
as eluant, provided the ring-opening product.
Deprotection procedure
Deprotection of rac-6 to rac-29 2-amino-1-phenylbutane.
A
suspension of Raney Ni in water (from TCI, ~3 mL) was added
to a solution of dithiane rac-6 (187 mg, 0.500 mmol) in EtOH
(10◦.0 mL). The mixture was stirred under H2 (1 atm) for 20 h at
80 C. The resulting mixture was diluted with CH2Cl2 (~50 mL)
and H2O (~100 mL). The aqueous layer was extracted with CH2Cl2
(~50 mL ¥ 2) twice, dried over Na2SO4, filtered and concentrated.
The crude product was purified by flash chromatography (AcOEt–
hexane = 5 : 1, v/v, ref 0.25) to isolate dithiane-free material
(126 mg, 0.468 mmol, 93.7% yield.
Next, the tert-butylsulfamide moiety was deprotected by us-
ing the conditions and the isolation procedures developed by
Weinreb.21 Sulfoamide (60.0 mg, 0.227 mmol) in CH2Cl2 (10.0mL),
anisole (491 mg, 4.54 mmol) and TfOH (2.27 mmol in CH2Cl2
10.0 mL) were used. The crude product was purified by flash
chromatography (AcOEt–MeOH–NEt3 = 9 : 1 : 0.05, v/v, ref 0.2)
to afford the amine rac-29 (16.8 mg, 0.113 mmol, 49.8% yield).
Spectral data coincided with the previous data.39
Typical procedure B. A solution of 2-CO2H-1,3-dithiane
(90.4 mg, 0.550 mmol, 1.10 equiv.) in THF (3.50 mL) was cooled
to 0 ◦C and treated with a ~1.6 M hexane solution of nBuLi
(1.10 mmol, 2.20 equiv.) dropwise via syringe. After 10 min, a
solution of assigned aziridine (0.500 mmol) in THF (2.00 mL)
and TMEDA (0.195 mL, 1.30 mmol, 2.60 equiv.) was added
dropwise to the reaction mixture at 0 ◦C via syringe. The resultant
solution was warmed to 65 ◦C and stirred for 13 h. The resultant
mixture was poured into excess HCl in MeOH and concentrated
in vacuo. The residue was dissolved in CH2Cl2 (~50 mL), filtered
and concentrated in vacuo. The resulting oil was dissolved in
CH2Cl2 (5.00 mL), DMAP (7.33 mg, 0.0600 mmol) and DCC
(124 mg, 0.600 mmol). The suspension was stirred for 1 h at room
temperature. Flash chromatography (AcOEt–hexane = 3 : 1, v/v)
provided the g-lactam.
Deprotection of (S)-25 to (S)-30
(S)-1-(2-Phenyl-1,3-dithian-2-yl)-2-(tert-butoxycarbonyl)-3-phe-
nylpropane. A 80 mL Schlenk flask equipped with a magnetic
stirring bar was charged with (S)-25 (1.30 g, 2.15 mmol)
and DMAP (26.3 mg, 0.263 mmol). They were dissolved in
CH2Cl2 (10.0 mL) and NEt3 (435 mg, 4.30 mmol). Boc2O (1.10 g,
5.00 mmol) was dropped in one portion into the resultant solution.
The reaction mixtur◦e was stirred for 2 h at room temperature
and overnight at 40 C. The solution was concentrated in vacuo
and the residue was treated with EtOAc and excess 1M HCl.
The EtOAc was washed with brine twice, dreid (NaSO4) and
concentrated to leave a viscous solid. The material obtained was
used without further purification.
Typical procedure C. A solution of 2-Me3Si-1,3-dithiane
(106 mg, 0.550 mmol, 1.10 equiv.) in Et2O (3.00 mL) was cooled
◦
t
to -78 C and treated with a ~1.5 M pentane solution of BuLi
(0.550 mmol, 1.10 equiv.) dropwise via syringe. The resulting
solution was warmed to -45 ◦C over 1 h and then cooled to
-78 ◦C. A solution of assigned aziridine (0.500 mmol) in Et2O
(2.00 mL) was added dropwise to the reaction mixture at -78 ◦C
via syringe. The resultant solution was warmed to -20 ◦C over
15 min, and stirred for an additional 3 h at 0 ◦C. The isolation
procedure was the same as described in typical procedure A.
The crude material in THF (20 mL) was treated with TBAF in
1M THF solution (10 mL). Following stirring at room temperature
for 2 h, the solvents were removed under reduced pressure.
Purification of the residue by column chromatography (hexane–
AcOEt = 5 : 1, v/v) yielded a colorless liquid (S)-30 (1.01 g,
2.35 mmol, 90% yield). The characteristics of (S)-30 were as
follows: Rf = 0.50 (hexane–EtOAc = 5 : 1, v/v); 1H NMR (CDCl3):
d 1.35 (s, 9H), 2.08–2.30 (m, 2H), 2.45–2.83 (m, 6H), 3.55–4.18
(m, 2H) 6.91–7.07 (m, 2H), 7.13–7.30 (m, 4H), 7.35 (t, J = 8.0 Hz,
2H), 7.85 (d, J = 8.5 Hz, 2H); 13C NMR (CDCl3): d 24.93, 27.53,
28.42, 42.28, 48.29, 48.70, 57.51, 78.69, 126.19, 127.10, 128.22,
128.62, 128.68, 129.45, 137.98, 141.08, 154.44; IR (KBr disc): 1028,
1051, 1171, 1246, 1275, 1364, 1389, 1499, 1508, 1701, 2907, 2974,
3368 cm-1. Calcd for C24H31NO2S2: C, 67.09; H, 7.27; N, 3.26.
Typical procedure D. The molar ratio was the same as de-
scribed in typical procedure A. The resultant solution was warmed
to 30 ◦C and stirred for 12 h. The isolation procedure was the same
as described in typical procedure A.
Typical procedure E. A solution of carbinol (precursor of 26,
250 mg, 0.627 mmol, 1.25 equiv.) in Et2O (4.00 mL) was cooled
to 0 ◦C and treated with a ~1.6 M hexane solution of nBuLi
(0.627 mmol, 1.25 equiv.) dropwise via syringe (Scheme 7). The
◦
resulting solution was cooled to -78 C. A solution of assigned
aziridne (0.500 mmol) and HMPA (0.41 mmol, 0.820 equiv.) in
Et2O (2.00 mL) was added dropwise to the reaction mixture at
◦
◦
-78 C via syringe. The resultant solution was warmed to 0 C,
◦
and stirred for an additional 3 h at 0 C. The resultant mixture
was poured into aqueus NH4Cl and concentrated in vacuo. Flash
Found: C, 67.01; H, 7.40; N, 3.21. [a]21 = 0.342 (c 9.11 in Et2O).
D
506 | Org. Biomol. Chem., 2009, 7, 502–507
This journal is
The Royal Society of Chemistry 2009
©